An Initiative by SAARTHI IAS
Maarg Manthan · Topic 18.25

Present world scenario of IPR related to life materials: global scenario, India’s position, reasons for less commercialisation

Indian Economy › External Sector: BoP, Forex and Trade · Topic 18.25

Intellectual property rights (IPR) related to life materials cover patents, plant variety rights and other protection for genes, microorganisms, plants, animals, biological processes and associated traditional knowledge. Globally, TRIPS Article 27.3(b) allows members to exclude plants and animals from patents but requires protection of microorganisms and plant varieties, and the WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge, adopted on 24 May 2024, requires patent applicants to disclose the origin of genetic resources and will enter into force three months after 15 ratifications. India excludes plants, animals and essentially biological processes from patents under Section 3(j) of the Patents Act, 1970, and protects plant varieties and biodiversity through separate laws. Commercialisation remains low because of limited translational research, funding, long timelines and regulatory complexity.

Share:
Present world scenario of IPR related to life materials: global scenario, India’s position, reasons for less commercialisation - Indian Economy - MaargX UPSC Maarg Manthan

At a Glance

  • TRIPS provision Article 27.3(b): plants and animals may be excluded, microorganisms must be protected
  • WIPO genetic resources treaty Adopted 24 May 2024, disclosure of origin
  • Entry into force Three months after 15 ratifications
  • India’s patent exclusion Section 3(j) of the Patents Act, 1970
  • India’s biodiversity law Biological Diversity Act, 2002
  • India’s innovation rank 38th in the Global Innovation Index 2025
  • Exam link UPSC Prelims and Mains, Indian Economy: External Sector: BoP, Forex and Trade

Where Does It Fit?

This is the Mains view that builds on WTO and Intellectual Property Rights: TRIPS Minimum Standards and Enforcement; Patents Act 1970; Patents (Amendment) Rules 2021; Patentability Criteria; Term of Patent; Evergreening; Compulsory Licensing; Geographical Indications (GI) and GI Tag Products; Copyright; Trademark; DPIIT as Nodal Agency; WIPO and World IP Day on WTO and IPR and links to IPR related to life materials on life materials. The innovation index context is in Human Development Report (UNDP); Gender Development Index; World Bank Indices (Doing Business Legacy); WIPO Global Innovation Index. Previous topic: Internationalisation of the rupee: meaning, benefits, challenges, measures. Next topic: India’s BoP performance and CAD sustainability.

What Is the Global Scenario on IPR for Life Materials?

Instrument Provision Significance
TRIPS Agreement, Article 27.3(b) Members may exclude plants and animals and essentially biological processes from patents but must protect microorganisms and non-biological and microbiological processes, and provide protection for plant varieties by patents or an effective sui generis system The basic global rule, reviewed in the WTO
Budapest Treaty Recognises the deposit of microorganisms with an international depositary authority for patent purposes Makes it easier to meet disclosure requirements for biological inventions
Convention on Biological Diversity and Nagoya Protocol Provide for access to genetic resources and fair and equitable sharing of benefits Link patents to benefit sharing with source countries and communities
WIPO Treaty on IP, Genetic Resources and Associated Traditional Knowledge Adopted on 24 May 2024. Patent applicants must disclose the country of origin or source of genetic resources and associated traditional knowledge used in a claimed invention Enters into force three months after 15 ratifications and applies only to patents filed after that
UPOV Convention Provides plant breeders’ rights through a model system Contrasts with farmers’ rights models, such as India’s
Trend Rising patenting in biotechnology, gene editing and synthetic biology Debate on access, biopiracy and benefit sharing
Biopiracy concern Patents on products derived from traditional knowledge without consent or benefit sharing Drives the push for disclosure of origin

What Is India’s Position and Why Is Commercialisation Low?

Aspect Facts and analysis
Patents Act, 1970 Section 3(j) excludes plants, animals and essentially biological processes for production or propagation, and Section 3(d) bars patents on new forms of known substances without enhanced efficacy
Plant variety law The Protection of Plant Varieties and Farmers’ Rights Act, 2001 gives breeders’ rights and recognises farmers’ rights to save, use and exchange seeds
Biodiversity law The Biological Diversity Act, 2002 regulates access to biological resources and benefit sharing through the National Biodiversity Authority, and India is a party to the Nagoya Protocol
Traditional knowledge India maintains a Traditional Knowledge Digital Library to prevent wrongful patents on traditional knowledge
Policy push The BioE3 policy of 2024 on biotechnology for economy, environment and employment aims to boost bio-manufacturing and innovation
Innovation standing India ranked 38th in the Global Innovation Index 2025, up from 66th in 2019
Treaty stance India welcomed the WIPO treaty and would need changes to the Patents Act to implement disclosure obligations when it ratifies

What Else Should You Remember?

  • Also called: Life materials include biological material such as genes, cells, microorganisms, seeds and plants. sui generis means a separate special system of protection. TK means traditional knowledge
  • Reasons for low commercialisation: Weak links between research institutions and industry, limited venture and early-stage funding, long gestation and high cost of biotech development, regulatory complexity, shortage of translational infrastructure and skills
  • Regulatory complexity: Approvals by several bodies for biological products and genetically modified organisms lengthen timelines
  • Patent eligibility limits: Exclusions in Section 3(j) and Section 3(d) limit patent claims on plants and incremental drug changes, though they also protect access and affordability
  • Balance of interests: The law balances innovation incentives with farmers’ rights, biodiversity conservation and public health
  • Link to startups: Biotech startups need funding and incubation, as in Startups: Startup India; Seed Fund Scheme; DPIIT Recognition
  • Link to WTO issues: TRIPS flexibilities and public health are part of India’s position at the WTO, as in WTO and India: issues (agriculture subsidies, public stockholding, TRIPS)
  • Way forward: Build translational research centres, expand early-stage funding, simplify and speed regulation, strengthen patent examination and traditional knowledge protection, and align with the WIPO treaty
  • Model answer tip: Give the global instruments, then India’s laws, then reasons for low commercialisation and end with a balanced way forward
  • Common errors: Writing that India allows patents on all life forms. It excludes plants, animals and essentially biological processes
  • Another common error: Assuming the WIPO treaty is already in force. It enters into force after 15 ratifications

Why Does It Matter for the Exam?

  1. TRIPS: Article 27.3(b)
  2. WIPO treaty: 24 May 2024, disclosure of origin, 15 ratifications
  3. Patents Act: Section 3(j) and Section 3(d)
  4. Plant law: PPV&FR Act, 2001
  5. Biodiversity law: Biological Diversity Act, 2002

As an analytical point, IPR for life materials must balance rewards for innovation with access, biodiversity and benefit sharing. India’s laws reflect that balance, but low commercialisation shows that protection alone does not create innovation: funding, regulation and translation matter as much.

Why Is This Topic Important?

  • Global TRIPS, WIPO treaty, Nagoya
  • India Patents Act, PPV&FR, BD Act
  • Gap Commercialisation

What Came Next?

The next topic covers India’s balance of payments performance and current account deficit sustainability. Next topic: India’s BoP performance and CAD sustainability.

Key People and Terms

  • Life materials Biological material such as genes and seeds
  • Sui generis Special separate system
  • Biopiracy Unauthorised use of biological resources or knowledge
  • ABS Access and benefit sharing
  • TKDL Traditional Knowledge Digital Library
  • UPOV Plant breeders’ rights convention

Exam Corner

Points to Remember

  • TRIPS: Article 27.3(b).
  • WIPO treaty: 24 May 2024, 15 ratifications.
  • Patents Act: 3(j) and 3(d).
  • PPV&FR Act: 2001.
  • Biological Diversity Act: 2002.

Do Not Confuse With

  • Patent and plant variety right Invention monopoly versus breeders’ and farmers’ rights
  • Disclosure of origin and benefit sharing Patent application requirement versus sharing profits with source communities
  • Biopiracy and biodiversity law Wrongful appropriation versus access regulation

Memory Hook

TRIPS allows exclusion, WIPO demands disclosure, India balances with 3(j) and farmers’ rights.

Mains Angle

Mains questions ask about global rules, India’s position and low commercialisation. These points give a frame.

  • Global TRIPS, WIPO, Nagoya
  • India Laws and balance
  • Gap Translation and funding

A Question You May Face

An original practice question, not a past paper question.

“Discuss the global scenario of IPR on life materials and why commercialisation of biotechnology research in India remains low.”

How to Answer

  1. Intro Life materials and IPR.
  2. Global TRIPS and WIPO treaty.
  3. India Laws and BioE3.
  4. Conclude Translate research into products.

GS Relevance

GS Paper 3: IPR, biotechnology, science and technology, biodiversity; GS Paper 2: international agreements.

Frequently Asked Questions

What does TRIPS say about patents on life forms?

Article 27.3(b) of TRIPS lets members exclude plants and animals and essentially biological processes from patents, but requires protection for microorganisms and non-biological and microbiological processes, and for plant varieties through patents or an effective sui generis system.

What is the WIPO treaty on genetic resources and traditional knowledge?

The WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge, adopted on 24 May 2024, requires patent applicants to disclose the country of origin or source of genetic resources and associated traditional knowledge, and it enters into force three months after 15 ratifications.

How does India treat patents on plants and animals?

Section 3(j) of the Patents Act, 1970 excludes plants, animals and essentially biological processes from patents, and plant varieties are protected under the Protection of Plant Varieties and Farmers' Rights Act, 2001, which also recognises farmers' rights to save, use and exchange seeds.

What is biopiracy?

Biopiracy is the unauthorised use or patenting of biological resources or associated traditional knowledge without the consent of the source country or communities and without benefit sharing, which disclosure requirements and access and benefit sharing laws aim to prevent.

Why is commercialisation of biotech research low in India?

The reasons include weak research-industry links, limited early-stage and venture funding, long timelines and high costs, regulatory complexity across multiple bodies and a shortage of translational infrastructure and skills, which make it hard to turn research into products.

What is the BioE3 policy?

The BioE3 policy, approved in 2024, stands for biotechnology for economy, environment and employment. It aims to boost bio-manufacturing, innovation and green growth by supporting research, translation and industry in biotechnology, and by building bio-manufacturing hubs and skills.

PYQ Practice — Statement Analysis

1 TRIPS Article 27.3(b) allows members to exclude plants and animals from patents.
True

Microorganisms must be protected.

2 The WIPO genetic resources treaty is already in force.
False

It enters into force three months after 15 ratifications.

3 Section 3(j) of India's Patents Act excludes plants and animals.
True

It also excludes essentially biological processes.

4 India allows patents on all life forms.
False

Plants, animals and biological processes are excluded.

5 The Biological Diversity Act, 2002 regulates access and benefit sharing.
True

The National Biodiversity Authority administers it.

Share: